These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Indinavir (Crixivan) access and distribution.
    Author: James JS.
    Journal: AIDS Treat News; 1996 Apr 05; (no 244):3-5. PubMed ID: 11363304.
    Abstract:
    Merck's indinavir (Crixivan) will be available in limited supplies through the end of the year until the company's new production facilities open. Merck established a complex distribution system to ensure that patients who begin indinavir treatment will be able to continue uninterrupted use of the drug. The company will temporarily use only one mail-order pharmacy, Stadtlanders, to track and fill all orders for the drug. The complex distribution system and some of its potential problems are described. Indinavir costs $5,820 per year, which may be covered by medical insurance. In some cases, Merck will work with patients on finding payment sources.
    [Abstract] [Full Text] [Related] [New Search]